If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurface Transforms Regulatory News (SCE)

  • This share is currently suspended. It was suspended at a price of 0.112
  • There is currently no data for SCE

New manufacturing strategy

2 Sep 2021 07:01

RNS Number : 4649K
Surface Transforms PLC
02 September 2021
 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

2 September 2021

Surface Transforms plc

("Surface Transforms" or the "Company")

New manufacturing strategy

Surface Transforms (AIM:SCE), manufacturers of carbon fibre reinforced ceramic brake discs, is pleased to announce that, following internal analysis and extensive discussions with its furnace supplier partners, it is updating its manufacturing strategy which will have the effect of:

· saving approximately £10 million in equipping the entire Knowsley factory

· increasing 2023 sales capacity by £15 million p.a. from £35 million p.a. to £50 million p.a. with no new capital equipment cash requirement

· reducing implementation time for equipping the entire factory by approximately 18 months

· significantly increasing capacity implementation flexibility beyond 2022 as the business grows over the next 2 to 3 years

· reducing Surface Transforms' projected carbon footprint using more environmentally friendly furnace technology

By way of background, the Company has until now, had the strategy of equipping the Knowsley factory in a series of five modular, relatively independent but identical production cells, being built at one cell roughly every 18 months at a cost of approximately £10 million per cell. Cell One is complete. The Company raised £20 million in February 2021 to equip Cell Two and to provide additional working capital enabling site capacity for £35 million sales when complete in early 2023.

Following the fund raise, the Company and its furnace supplier partners examined the options for building not just Cell Two but also ensuring that the factory will have the required level of equipment over the next few years. The Board subsequently concluded that improvements could be made to the previous manufacturing strategy, noting that:

· The primary objective remains to ultimately provide a factory with sales capacity of £75 million p.a.

· However, the Company will no longer build separate production cells but approach the project as a plant-wide "single production line" project

· This includes seeing the procurement of the furnaces (about two thirds of the cost and all the lead time) as being very different from that of the machine tools and other equipment

· Following advice from the furnace suppliers and internal evaluation the Company will now procure a smaller number of larger furnaces to support the sales capacity target for the Knowsley factory of £75 million p.a.

· The immediate effect is to raise the 2023 capacity availability from the fundraising projection of £35 million p.a. sales to £50 million p.a. sales with no impact on the 2022 cash requirement

· The procurement of the other machine tools is now in "buckets" of circa £5 million p.a. capacity (previously circa £15 million p.a.) giving the Company shorter lead times and greater flexibility to deal with shorter lead time customer requests that we have seen more recently from some customers. It should also be possible to asset finance a large proportion of the machine tool purchases as the Company moves into profitability

· The nearer term additional production capacity that this new strategy provides means the Company can await contract awards before needing to buy further furnaces to increase sales from £50 million to £75 million

· During the fund raise the Company stated that it expected it would cost approximately £50 million to provide sales capacity of £75 million p.a. of which £10 million had been spent and the fund raise included £10 million for Cell Two capital equipment. This total requirement is now reduced to £40 million, a saving of £10 million

· Working capital cash needs remain unchanged. This announcement only impacts capital expenditure

Upon completion of this project there will no longer be any self-contained complete production cells in Knowsley. The technologies will be grouped together, and work-in-progress will flow from one technology to the next in a lean environment. The machines in the current SVP Cell and production Cell One will be moved to the appropriate new location in the new factory layout.

Kevin Johnson, CEO, commented:

"At the time of the fund raising we said that we thought there could be sufficient demand to fill the Knowsley factory by 2025, albeit the sales were then, and are still now, only partially contracted. Our continuing discussions with existing and potential customers together with increasingly encouraging test results have not only lifted our confidence in this view but led us to the conclusion that we may require this capacity by 2024. This new manufacturing strategy will achieve the primary capacity objective with the added benefit of reducing overall capital expenditure. There are numerous positive cash implications, and we continue to work with our customers to convert the significant number of active projects into firm agreements to fill this capacity."

For enquiries, please contact:

Surface Transforms plc. +44 151 356 2141

David Bundred, Chairman

Kevin Johnson, CEO

Michael Cunningham, CFO

 

Zeus Capital Limited (Nominated Adviser and Joint Broker) + 44 203 829 5000 

David Foreman / Dan Bate / Jordan Warburton (Corporate Finance)

Dominic King (Corporate Broking)

finnCap Limited (Joint Broker) +44 207 220 0500

Ed Frisby / Abigail Kelly (Corporate Finance)

Richard Chambers / Barney Hayward (ECM)

About Surface Transforms

Surface Transforms plc. (AIM:SCE) develops and produces carbonceramic material automotive brake discs. The Company is the UK's only manufacturer of carbonceramic brake discs, and only one of two mainstream carbon-ceramic brake disc companies in the world, serving customers that include major OEMs in the global automotive markets.

The Company utilises its proprietary next generation Carbon Ceramic Technology to create lightweight brake discs for highperformance road and track applications for both internal combustion engine and electric vehicles. While competitor carbonceramic brake discs use discontinuous chopped carbon fibre, Surface Transforms interweaves continuous carbon fibre to form a 3D matrix, producing a stronger and more durable product with improved heat conductivity compared to competitor products; this reduces the brake system operating temperature, resulting in lighter and longer life components with superior brake performance. These benefits are in addition to the benefits of all carbonceramic brake discs vs. iron brake discs: weight savings of up to 70%, longer product life, consistent performance, reduced brake pad dust and corrosion free.

For additional information please visit www.surfacetransforms.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFLFFTARILIIL
Date   Source Headline
1st May 20207:00 amRNSResult of over-subscribed open offer
24th Apr 20204:17 pmRNSHolding(s) in Company
23rd Apr 202011:35 amEQSHardman & Co Research: Q&A with Mike Foster on Surface Transforms (SCE): High visibility for 2021 onwards; equity raise
21st Apr 20207:00 amRNSOpen Offer application form - update
20th Apr 202010:20 amRNSHolding(s) in Company
17th Apr 20203:15 pmEQSHardman & Co Research: Surface Transforms (SCE): High visibility for 2021 onwards; equity raise
9th Apr 20203:00 pmRNSPlacing and Open Offer
27th Mar 20207:00 amRNSDeferral of Publication of Results &COVID19 Update
28th Feb 20207:00 amRNSUnaudited interims for the 6 m/e 30 November 2019
10th Feb 20208:27 amRNSHolding(s) in Company
28th Jan 20205:30 pmRNSAppointment of Sales Director and Grant of Options
27th Jan 20202:00 pmRNSDirector/PDMR Shareholding
10th Jan 20207:00 amRNSTrading and operational update
5th Dec 20197:00 amRNSGrant of options
13th Nov 20198:33 amRNSExercise of options
13th Nov 20198:27 amRNSResult of AGM
6th Nov 201910:01 amRNSHolding(s) in Company
6th Nov 20199:00 amRNSExercise of Options and PDMR Dealing
25th Oct 201912:56 pmEQSHardman & Co Research : Surface Transforms (SCE): Recent major contract wins transform prospects
17th Oct 20197:00 amRNSPosting of Annual Report and Notice of AGM
2nd Oct 201910:55 amRNSDirector/PDMR Shareholding
26th Sep 20197:00 amRNSContract award from OEM 1
19th Sep 20197:00 amRNSCapital Markets Day
18th Sep 201910:50 amRNSHolding(s) in Company
9th Sep 20197:00 amRNSPreliminary results and notice of AGM
5th Sep 20194:10 pmEQSHardman & Co Research: Surface Transforms (SCE): Rapid acceleration - 'game-change' announcements
27th Aug 20197:00 amRNSContract Agreement with German OEM 5
15th Aug 20197:00 amRNSChange of Financial Year End Date
16th Jul 20197:00 amRNSContract award from German OEM 5
28th Jun 20197:00 amRNSContract Awards and Commercial Settlement
16th May 20197:00 amRNSDirector/PDMR Shareholding
7th May 20199:05 amRNSSecond Price Monitoring Extn
7th May 20199:00 amRNSPrice Monitoring Extension
7th May 20197:00 amRNSTrading Update
28th Mar 20197:00 amRNSDirector/PDMR Shareholding
25th Mar 20195:05 pmRNSHolding(s) in Company
20th Mar 20197:00 amRNS£1.9 million placing
26th Feb 20197:00 amRNSInterim Results
11th Dec 20185:36 pmRNSResult of AGM
6th Dec 20187:00 amRNSExercise of Options and Director Dealing
5th Dec 20187:00 amRNSGrant of Options
4th Dec 20187:00 amRNSTrading & Operational Update
17th Sep 20187:00 amRNSPreliminary Results and Notice of AGM
10th Sep 20187:00 amRNSBoard appointment
4th Jul 20183:19 pmRNSGrant of options
3rd Jul 20187:00 amRNSHolding(s) in Company
27th Jun 20188:38 amRNS£1.5 Million Placing
13th Jun 20187:00 amRNSPre Close Trading, Customer and Operations Update
10th May 20187:00 amRNSDirector/PDMR Shareholding
12th Apr 20187:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.